Ribavirin

interferon alpha 1 ; Homo sapiens







377 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
351 11093071 Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis. 2000 1
352 11114411 Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytes. 2000 Nov 1
353 11132533 [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response]. 2000 Nov 1
354 16498353 Therapy for chronic hepatitis C. Present status. 2000 Jun 1
355 18034536 Interferon-alpha alone versus interferon-alpha plus ribavirin in patients with chronic hepatitis C not responding to previous interferon-alpha treatment. 2000 Apr 1
356 10192200 Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group. 1999 Feb 1
357 10349692 Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C. 1999 4
358 10405886 Enhancing the response to interferon-alpha. 1999 Jun 2
359 10419923 Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis. 1999 Aug 8
360 10438811 Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C. 1999 Sep 4
361 10494606 Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C. 1999 Aug 3
362 10581390 Suppression of interferon response gene expression in cells persistently infected with mumps virus, and restoration from its suppression by treatment with ribavirin. 1999 Dec 15 2
363 10616260 Utilizing daily interferon (alpha 2b) and ribavirin combination therapy in chronic hepatitis C: a preliminary report. 1999 Dec 3
364 10622581 Treatment of naive patients with chronic hepatitis C. 1999 1
365 10760037 Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon-alpha in interferon nonresponders with chronic hepatitis C. 1999 Jul 1
366 11291251 Hepatitis C viral dynamics. 1999 Nov 1
367 9458644 [Treatment response in chronic hepatitis C. Content of virus in serum is decisive for the outcome]. 1998 Jan 7 1
368 9658373 Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients. 1998 May 2
369 9860407 Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study. 1998 Dec 2
370 9862245 Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. 1998 Dec 6
371 9181527 Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial. 1997 May 4
372 9186825 Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. 1997 May 7
373 9407357 Current therapeutic trends in therapy for chronic viral hepatitis. 1997 Oct 1
374 9011471 Interferon-ribavirin combination therapy for chronic hepatitis C. 1996 Dec 2
375 7629562 Treatment with ribavirin+alpha interferon in HCV chronic active hepatitis non-responders to interferon alone: preliminary results. 1995 Feb 1
376 7521308 A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. 1994 Sep 6
377 7949457 Treatment of chronic viral hepatitis. 1994 Jun 1